Endocrine disorders: Causes of hyponatremia not to neglect

Annals of Medicine

Volumn 43, Issue 3, 2011, Pages 179-187

  Liamis, George ^a   Milionis, Haralampos J ^a   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adrenal insuffi ciency; hyponatremia; hypopituitarism; hypothyroidism; syndrome of inappropriate antidiuresis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; NONSTEROID ANTIINFLAMMATORY AGENT; RENIN INHIBITOR; TACROLIMUS;

ADDISON DISEASE; ADRENAL CORTEX INSUFFICIENCY; HUMAN; HYPERKALEMIA; HYPOALDOSTERONISM; HYPONATREMIA; HYPOPITUITARISM; HYPOTENSION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; LABORATORY TEST; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 79953879704     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.530680     Document Type: Review

References (72)

1. Pham PC, Pham PM, Pham PT. Vasopressin excess and hyponatremia. Am J Kidney Dis. 2006;47:727-37.
2. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21:70-6. (Pubitemid 43057112)
3. Small M, MacCuish AC, Thomson JA. Missed Addisonian crisis in surgical wards. Postgrad Med J. 1987;63:367-9. (Pubitemid 17063794)
4. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ. 2002;166:1056-62. (Pubitemid 34304651)
5. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102:164-8. (Pubitemid 15157162)
6. Gross PA, Ketteler M, Hausmann C, Ritz E. The charted and the uncharted waters of hyponatremia. Kidney Int Suppl. 1987;21:S67-75.
7. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-9. (Pubitemid 30340505)
8. Hoorn EJ, Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron Physiol. 2008;108:46-59.
9. Hoorn EJ, Halperin ML, Zietse R. Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM. 2005;98:529-40. (Pubitemid 41418674)
10. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol. 2009;161:11-20.
11. Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insuffi -ciency: report on 28 cases. Eur J Endocrinol. 2003;148: 609-17. (Pubitemid 36758290)
12. Oelkers W. Adrenal insuffi ciency. N Engl J Med. 1996;335: 1206-12.
13. Arlt W, Allolio B. Adrenal insuffi ciency. Lancet. 2003;361: 1881-93.
14. Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol. 1998;138:16-25. (Pubitemid 28078804)
15. Bornstein SR. Predisposing factors for adrenal insuffi ciency. N Engl J Med. 2009;360:2328-39.
16. Tsigos C, Arai K, Latronico AC, DiGeorge AM, Rapaport R, Chrousos G P. A novel mutation of the adrenocorticotro-pin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid defi ciency, but no ACTH-R abnormalities in two families with the triple A syndrome. J Clin Endocrinol Metab. 1995;80:2186-9.
17. Schambelan M, Sebastian A. Hyporeninemic hypoaldos-teronism. Adv Intern Med. 1979;24:385-405.
18. Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160-70. (Pubitemid 34790795)
19. Bogdanovic R, Stajic N, Putnik J, Paripovic A. Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review. Pediatr Nephrol. 2009;24:2167-75.
20. Proctor G, Linas S. Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling. Am J Kidney Dis. 2006;48:674-93. (Pubitemid 44402843)
21. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169-72. (Pubitemid 26083989)
22. Vance ML. Hypopituitarism. N Engl J Med. 1994;330: 1651-62. (Pubitemid 24166867)
23. Velardo A, Pantaleoni M, Zizzo G, Del Rio G, Coletta F, Carani C, et al. Isolated adrenocorticotropic hormone defi -ciency secondary to hypothalamic defi cit of corticotropin releasing hormone. J Endocrinol Invest. 1992;15:53-7.
24. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. Clinical case seminar: lymphocytic hypophysitis: clinicopathological fi ndings. J Clin Endocrinol Metab. 1995;80:2302-11.
25. Andrioli M, Pecori Giraldi F, Cavagnini F. Isolated cortico-trophin defi ciency. Pituitary. 2006;9:289-95.
26. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopi-tuitarism. N Engl J Med. 1989;321:492-6. (Pubitemid 19203872)
27. Ishikawa S, Schrier RW. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and miner-alocorticoid defi cient rats. Kidney Int. 1982;22:587-93. (Pubitemid 13204101)
28. Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:1820-32. (Pubitemid 44036166)
29. Raff H. Glucocorticoid inhibition of neurohypophysial vasopressin secretion. Am J Physiol. 1987;252:R635-44.
30. Saito T, Ishikawa SE, Ando F, Higashiyama M, Nagasaka S, Sasaki S. Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-defi cient rats. Am J Phys-iol Renal Physiol. 2000;279:F502-8.
31. Linas SL, Berl T, Robertson GL, Aisenbrey GA, Schrier RW, Anderson RJ. Role of vasopressin in the impaired water excretion of glucocorticoid defi ciency. Kidney Int. 1980; 18:58-67. (Pubitemid 10044815)
32. Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol. 2010;125:S226-37.
33. Devdhar M, Ousman YH, Burman KD. Hypothyroidism. Endocrinol Metab Clin North Am. 2007;36:595-615, v. (Pubitemid 47126257)
34. Shakir MK, Krook LS, Schraml FV, Hays JH, Clyde PW. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid. 2008; 18:787-92. (Pubitemid 352009938)
35. Warner MH, Holding S, Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol (Oxf). 2006;64: 598-9.
36. Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet. 1997;350:755-6. (Pubitemid 27387200)
37. Archambeaud-Mouveroux F, Dejax C, Jadaud JM, Vincent D, Laroumagne G, Hessel L, et al. [Myxedema coma with hypervasopressinism. 2 cases]. Ann Med Interne (Paris). 1987;138:114-8.
38. Schmitz PH, de Meijer PH, Meinders AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth J Med. 2001;58:143-9. (Pubitemid 32184549)
39. Smith JC, Siddique H, Corrall RJ. Misinterpretation of serum cortisol in a patient with hyponatraemia. BMJ. 2004;328:215-6. (Pubitemid 38147077)
40. Soule S. Addison's disease in Africa - a teaching hospital experience. Clin Endocrinol (Oxf). 1999;50:115-20. (Pubitemid 29079376)
41. Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fl uid volume in hyponatremia. Am J Med. 1987;83:905-8. (Pubitemid 18098166)
42. van der Hoek J, Hoorn EJ, de Jong GM, Janssens EN, de Herder WW. Severe hyponatremia with high urine sodium and osmolality. Clin Chem. 2009;55:1905-8.
43. Cherney DZ, Davids MR, Halperin ML. Acute hyponatrae-mia and'ecstasy': insights from a quantitative and integrative analysis. QJM. 2002;95:475-83. (Pubitemid 34814667)
44. Gagnon RF, Halperin ML. Possible mechanisms to explain the absence of hyperkalaemia in Addison's disease. Nephrol Dial Transplant. 2001;16:1280-4. (Pubitemid 32547390)
45. Chung DK, Hubbard WW. Hyponatremia in untreated active pulmonary tuberculosis. Am Rev Respir Dis. 1969; 99:595-7.
46. Lee P, Ho KK. Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production. Chest. 2010; 137:207-8.
47. da Silva CT Jr, Monteiro FM, Cardoso GP. [Endocrine and metabolic manifestations in tuberculosis]. Rev Port Pneu-mol. 2003;9:353-8. (Pubitemid 37258651)
48. Kinjo T, Higuchi D, Oshiro Y, Nakamatsu Y, Fujita K, Nakamoto A, et al. Addison's disease due to tuberculosis that required differentiation from SIADH. J Infect Chemother. 2009;15:239-42.
49. Yokoyama T, Toda R, Kimura Y, Mikagi M, Aizawa H. Addison's disease induced by miliary tuberculosis and the administration of rifampicin. Intern Med. 2009;48: 1297-300.
50. Ishikawa S, Saito T, Fukagawa A, Higashiyama M, Nakamura T, Kusaka I, et al. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hypo-natremia in elderly subjects. J Clin Endocrinol Metab. 2001;86:1665-71. (Pubitemid 32374921)
51. Foppiani L, Ruelle A, Bandelloni R, Quilici P, Del Monte P. Hypopituitarism in the elderly: multifaceted clinical and biochemical presentation. Curr Aging Sci. 2008;1:42-50.
52. Yamamoto T, Fukuyama J, Kabayama Y, Harada H. Dual facets of hyponatraemia and arginine vasopressin in patients with ACTH defi ciency. Clin Endocrinol (Oxf). 1998;49: 785-92. (Pubitemid 29009509)
53. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-72. (Pubitemid 46789896)
54. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42: 790-806.
55. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459-81, vii. (Pubitemid 36666228)
56. Musch W, Decaux G. Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. Int Urol Nephrol. 2001;32:475-93. (Pubitemid 32825445)
57. Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr Soc. 2001;49:788-92. (Pubitemid 32652473)
58. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008;3:1175-84.
59. Decaux G, Musch W, Penninckx R, Soupart A. Low plasma bicarbonate level in hyponatremia related to adrenocorticotro-pin defi ciency. J Clin Endocrinol Metab. 2003;88:5255-7. (Pubitemid 37452724)
60. Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insuffi ciency. J Clin Endocrinol Metab. 1994;79:923-31.
61. Hockings GI, Nye EJ, Grice JE, Jackson RV. Short synacthen test versus insulin stress test for the assessment of the hypothalamo-pituitary axis: controversy revisited again. Clin Endocrinol (Oxf). 1997;46:775-6. (Pubitemid 27304465)
62. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991; 72:773-8. (Pubitemid 21921764)
63. Crowley S, Hindmarsh PC, Honour JW, Brook CG. Repro-ducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol. 1993;136:167-72. (Pubitemid 23016125)
64. May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med. 1985;79: 679-84. (Pubitemid 16170124)
65. Thaler LM, Blevins LS Jr. The low dose (1-microg) adreno-corticotropin stimulation test in the evaluation of patients with suspected central adrenal insuffi ciency. J Clin Endo-crinol Metab. 1998;83:2726-9. (Pubitemid 28493767)
66. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary- adrenal axis. Clin Endocrinol (Oxf). 1994;40:603-9. (Pubitemid 24194663)
67. Borst GC, Michenfelder HJ, O'Brian J T. Discordant cortisol response to exogenous ACTH and insulin-induced hypogly-cemia in patients with pituitary disease. N Engl J Med. 1982;306:1462-4. (Pubitemid 12121578)
68. Streeten DH, Anderson GH Jr, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab. 1996;81:285-90. (Pubitemid 26035035)
69. Magnotti M, Shimshi M. Diagnosing adrenal insuffi -ciency: which test is best - the 1-microg or the 250-microg cosyntropin stimulation test? Endocr Pract. 2008;14: 233-8.
70. Pura M, Kreze A Jr, Kentos P, Vanuga P. The low-dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insuffi ciency: defi ning the normal cortisol response and report on fi rst patients with Addison disease confi rmed with LDT. Exp Clin Endocrinol Diabetes. 2010;118: 151-7.
71. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. 1995;80: 1238-42.
72. Oelkers W, Diederich S, Bahr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab. 1992;75: 259-64.